BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25863904)

  • 1. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
    Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
    Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
    Damhuis RA; Khakwani A; De Schutter H; Rich AL; Burgers JA; van Meerbeeck JP
    Lung Cancer; 2015 Aug; 89(2):212-7. PubMed ID: 26044908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
    Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
    Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
    Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
    Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
    Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
    Saddoughi SA; Abdelsattar ZM; Blackmon SH
    Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
    Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
    Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
    Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
    Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
    Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
    de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
    Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
    Remon J; Nadal E; Dómine M; Ruffinelli J; García Y; Pardo JC; López R; Cilleruelo A; García-Campelo R; Martín P; Juan O; González-Larriba JL; Provencio M; Olmedo E; Ponce S; Cumplido D; Barenys C; Majem M; Massutti B; Rodriguez-Abreu D; Porta R; Sala MA; Martinez-Kareaga M; Lianes P; Reguart N
    Lung Cancer; 2020 Sep; 147():83-90. PubMed ID: 32682189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.
    Takamori S; Toyokawa G; Taguchi K; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Seto T; Hirai F; Yamaguchi M; Shoji F; Okamoto T; Takenoyama M; Ichinose Y
    Clin Lung Cancer; 2017 Jul; 18(4):e303-e313. PubMed ID: 28274690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
    Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
    PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
    Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients.
    Koyuncu A; Koksal D; Ozmen O; Demirag F; Bayiz H; Aydogdu K; Berkoglu M
    J Cancer Res Ther; 2015; 11(1):216-22. PubMed ID: 25879365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
    Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
    Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
    Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
    Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.